Next-Generation Sequencing: Emerging Clinical Applications and Global Markets

1
Next-Generation Sequencing Emerging Clinical
Applications and Global Markets
2
Summary
The global clinical next-generation sequencing
(NGS) market was valued at 886.1 million in
2014. This market is expected to grow at a
compound annual growth rate (CAGR) of 31.3, from
997.1 million in 2015 to nearly 3.9 billion by
2020.This report provides-An overview of the
global market for next-generation sequencing and
its emerging clinical applications.-Analyses of
global market trends, with data from 2014,
estimates for 2015, and projections of CAGRs
through 2020.-Examination of the sequencing
industry structure for key market
segments.-Discussion covering the strategies
employed by the main companies in the
market.-Comprehensive company profiles of major
players in the field.
W www.bharatbook.com , T  91 22 27810772,
27810773, E  info_at_bharatbook.com
3
INTRODUCTIONSTUDY GOALS AND OBJECTIVESThis
Report Researchs goal for this study is to
provide an in-depth analysis of the clinical
next-generation sequencing (NGS) industry, an
emerging industry with enormous market potential.
The approach of analyzing the industry is taken
in terms of workflow (e.g., sequencers, sequence
capture, informatics) and key indications where
NGS diagnostics will have market share by
2020.This Research examines the markets for NGS
diagnostics for the years 2014, 2015 and
2020.The global NGS diagnostic markets are
characterized and quantified by disease
indication, test complexity, test purpose and
geography.Market segments that provide
exceptional growth opportunities include cancer,
rare genetic diseases and reproductive health.
W www.bharatbook.com , T  91 22 27810772,
27810773, E  info_at_bharatbook.com
4
The report provides a comprehensive discussion of
NGS technologies, clinical applications, industry
structure, important clinical sequencing
initiatives, global markets, patent status and
companies. The report is designed to aid
companies in their strategic planning efforts for
clinical genetic testing. REASONS FOR DOING THE
STUDY The Human Genome Project (HGP) moved DNA
sequencing technology to the forefront of life
science research as a genetic analysis tool. The
HGP relied heavily on Sanger sequencing by
capillary electrophoresis to decipher the DNA
sequence of the bases in the human genome.
W www.bharatbook.com , T  91 22 27810772,
27810773, E  info_at_bharatbook.com
5
The HGP led to significant improvements in the
efficiency and costs of DNA sequencing. During
this time period, the sequencing industry
consolidated, resulting in one dominant company,
Applied Biosystems (now Thermo Fisher
Scientific). Beginning in 2005, the launch of
next-generation sequencing technologies radically
changed the structure of the industry and opened
up exciting new market applications. The costs of
sequencing have rapidly reduced to the point
where it is now feasible for complex NGS tests to
be priced in the range of other multiplex genetic
tests.
W www.bharatbook.com , T  91 22 27810772,
27810773, E  info_at_bharatbook.com
6
CONTRIBUTION OF THE STUDY AND INTENDED
AUDIENCE This report fills a gap in the industry
by focusing solely on clinical applications run
on next-generation sequencing instruments.
Because this industry shows great promise,
information about the market will be particularly
useful to companies and other institutions. The
report provides a roadmap for understanding the
ways in which next-generation sequencing will be
used in the diagnostic business during the next
five years. It is a useful guide for strategic
and business planning, as well as for learning
about the impact new sequencing technologies will
have in clinical diagnostics.
W www.bharatbook.com , T  91 22 27810772,
27810773, E  info_at_bharatbook.com
7
This market report will be useful to many
companies involved in the clinical, genetic
testing and sequencing industries. It will be
particularly valuable for companies in such
industries as life science research tools, NGS
instruments, molecular diagnostics, informatics
clinical laboratories, pharmaceutical,
biotechnology, microfluidics, lab-on-a-chip and
sample preparation. SCOPE AND FORMAT The scope
of the report includes clinical NGS technologies,
applications, industries, initiatives, patents
and companies. The markets for NGS-based
diagnostics are given for the years 2014, 2015
and 2020.
W www.bharatbook.com , T  91 22 27810772,
27810773, E  info_at_bharatbook.com
8
Table of Contents

1. INTRODUCTION
2. EXECUTIVE SUMMARY
3. OVERVIEW
4. TECHNOLOGIES
5. TOP 10 CLINICAL NGS INITIATIVES
6. CLINICAL NGS APPLICATIONS
7. CLINICAL NGS INDUSTRY
8. NGS DIAGNOSTICS MARKETS

W www.bharatbook.com , T  91 22 27810772,
27810773, E  info_at_bharatbook.com
9
To view the full Executive Summary and Table of
Contents, please visit Next-Generation
Sequencing Emerging Clinical Applications and
Global Markets Contact UsBharat Book
BureauCall us 91-22-27810772 / 73Email id
info_at_bharatbook.com Blog https//www.bharatbook
.com/blog/
Follow Us On